Difference between revisions of "Team:UofC Calgary"

Line 254: Line 254:
 
     padding: 0px 20px 20px;">
 
     padding: 0px 20px 20px;">
 
                                   <h4 style="color:#EBDEBE">Project Description</h4>
 
                                   <h4 style="color:#EBDEBE">Project Description</h4>
                                             <p style="color: #FFFFFF">Mars and the cosmos are a tantalizingly close goal for Mankind to reach in the next century; however, there are several glaring problems that we must overcome to reach such an objective. Radiation is chief among them. On Earth, individuals annually receive 2.4 mSv of ionizing radiation (IR), which is easily tolerated by the human body. Unfortunately, without the protection of the magnetosphere, astronauts in space are exposed to high levels of IR in the range of 50 to 2000 mSv. This level of radiation causes the accumulation of deleterious double strand breaks in DNA. Despite current research into methods of IR protection, many solutions such as radiation shield coating are quite expensive, especially to transport to space. </p> <p style="color: #FFFFFF">
+
                                             <p style="color: #FFFFFF">Mars and the cosmos are a tantalizingly close goal for Mankind to reach in the next century; however, there are several glaring problems that we must overcome to reach such an objective. Radiation is chief among them. On Earth, individuals annually receive 2.4 mSv of ionizing radiation (IR), which is easily tolerated by the human body. Unfortunately, without the protection of the magnetosphere, astronauts in space are exposed to high levels of IR in the range of 50 to 2000 mSv. This level of radiation causes the accumulation of deleterious double strand breaks in DNA. Despite current research into methods of IR protection, many solutions such as radiation shield coating are quite expensive, especially to transport to space. Even existing biological solutions are insufficient, such as the use of ingestible or injectable radioprotectors, which are subject to sinusuoidal pharmacokinetics. Our project is based on the administration of the naturally occuring peptide Bowman-Birk Protease Inhibitor (BBI), which has been shown to confer protection against DNA damage following radiation exposure. (Dittmann <i>et al.</i>, 2003). </p>
  
Biological solutions, such as the use of ingestible or injectable radioprotectors, are subject to sinusoidal pharmacokinetics. The therapeutic is delivered once, and although it may be effective initially, it will be degraded over time by the body, dropping its efficiency rate. This results in the need to re-administer a drug regularly to maintain its activity in the body, so the dosage level resembles a sinusoidal curve. Certain naturally-occurring proteins and peptides, such as the Bowman-Birk Protease Inhibitor (BBI), have been found to confer protection against DNA damage in cells exposed to ionizing radiation. Previous studies have shown that BBI increases the survival rate of cells significantly after they are irradiated by augmenting endogenous DNA repair mechanisms (Dittmann <i>et al.</i>, 2003).
 
</p><p style="color: #FFFFFF">
 
 
To create a cost effective and continuous delivery system for IR protection during space travel, we have designed a transdermal patch for the delivery of a modified version of BBI (mBBI) through the skin. The patch hosts recombinant <i>Bacillus subtilis</i> cells that express mBBI with a transdermal tag that allows the peptide to travel through the layers of the skin and into the bloodstream for dispersal throughout the body. This recombinant protein is fused to a <i>B. subtilis</i>-specific secretory tag, which permits the peptide to be secreted into the growth medium. Using <i>B. subtilis</i> for the production of mBBI allows for constant delivery and resolves the issue of sinusoidal pharmacokinetics. This long term, continuous delivery is also cost effective and minimizes waste. Ultimately, our transdermal delivery patch allows for the administration of biotherapeutics within an efficient and practical system, while maintaining the flexibility of modularity, as <i>B. subtilis</i> could be used to produce a multitude of various peptides or small molecules with various therapeutic effects.
 
</p>
 
  
 
<p style="color: #FFFFFF">References</p>
 
<p style="color: #FFFFFF">References</p>

Revision as of 02:53, 18 October 2016

iGEM Calgary 2016

Our Project

Project Description

Mars and the cosmos are a tantalizingly close goal for Mankind to reach in the next century; however, there are several glaring problems that we must overcome to reach such an objective. Radiation is chief among them. On Earth, individuals annually receive 2.4 mSv of ionizing radiation (IR), which is easily tolerated by the human body. Unfortunately, without the protection of the magnetosphere, astronauts in space are exposed to high levels of IR in the range of 50 to 2000 mSv. This level of radiation causes the accumulation of deleterious double strand breaks in DNA. Despite current research into methods of IR protection, many solutions such as radiation shield coating are quite expensive, especially to transport to space. Even existing biological solutions are insufficient, such as the use of ingestible or injectable radioprotectors, which are subject to sinusuoidal pharmacokinetics. Our project is based on the administration of the naturally occuring peptide Bowman-Birk Protease Inhibitor (BBI), which has been shown to confer protection against DNA damage following radiation exposure. (Dittmann et al., 2003).

References

Dittmann, K.H., Mayer, C., and Rodemann, H.P. (2003). Radioprotection of normal tissue to improve radiotherapy: the effect of the Bowman Birk protease inhibitor. Current Medicinal Chemistry - Anticancer Agents, 3(5), 360-363.

OUR CHASSIS

Mars and the cosmos are a tantalizingly close goal for Mankind to reach in the next century; however, there are several glaring problems that we must overcome to reach such an objective. Radiation is chief among them. On Earth, individuals annually receive 2.4 mSv of ionizing radiation (IR), which is easily tolerated by the human body. Unfortunately, without the protection of the magnetosphere, astronauts in space are exposed to high levels of IR in the range of 50 to 2000 mSv. This level of radiation causes the accumulation of deleterious double strand breaks in DNA. Despite current research into methods of IR protection, many solutions such as radiation shield coating are quite expensive, especially to transport to space. Even existing biological solutions are insufficient, such as the use of ingestible or injectable radioprotectors, which are subject to sinusuoidal pharmacokinetics. Our project is based on the administration of the naturally occuring peptide Bowman-Birk Protease Inhibitor (BBI), which has been shown to confer protection against DNA damage following radiation exposure. (Dittmann et al., 2003)

Design Overview





We designed our project to overcome common issues in existing technologies such as cost, portability and durability. Our solution is superior to current technologies because our patch is portable, lightweight, safe to use, can be stored long-term, and produces and delivers peptides at a steady rate, which solves the issues of pharmacokinetics. We worked with professionals within NASA and the CSA to integrate our solution with current space travel infrastructure, and with companies specializing in transdermal delivery to optimize the delivery system.




Our Project

Project Description

Our Experiments

Modelling

Human Practices

Click to learn more about each part of our project

About us

The 2016 U of C Calgary iGEM team is a multidisciplinary team based out of the University of Calgary. Our team is made up of undergraduate students from all years of study, hailing from the broad backgrounds of biology, microbiology, biomedical sciences, bioinformatics, and engineering. We are based out of the O'Brien Centre Labs within the U of C's Health Science Centre.

Our Sponsors

iGEM

iGEM is an international competition promoting synthetic biology as a means to solve social, economic and humanitarian problems around the globe. The iGEM Jamboree is held in Boston annually. In 2016, over 300 teams are competing against each other.

Latest Entries

Fully Trained!

Our entire team received a full BioSafety education from the University of Calgary! This entailed going to classes to prepare for a final quiz that tested our ability to be safe in the lab. Several of our members also had radiation training and clearance to ensure that work done with radiation was safe!

Read More

Latest Pictures

View More

Find us

Located in Calgary, Alberta, Canada.

  • University of Calgary
  • igem.calgary@gmail.com